Initiated development of a second CAPTN-3 tri-specific antibody targeting TROP2 Manufacturing milestone achieved for IM1240, the first tri-specific 5T4-targeting antibody from the CAPTN-3 platform Cas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback